Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis

Cellular Oncology

Volumn 31, Issue 4, 2009, Pages 291-300

  Smeets, Serge J ^a   Brakenhoff, Ruud H ^a   Ylstra, Bauke ^a   Van Wieringen, Wessel N ^b   Van De Wiel, Mark A ^a,b   Leemans, C René ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Array CGH; Head and neck cancer; HPV; Oral cancer; Prognosis; TP53

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER GENETICS; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME ABERRATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MALE; MICROSATELLITE INSTABILITY; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; TP53 GENE; WART VIRUS; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS;

EID: 67650737329     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0471     Document Type: Article

References (45)

1. V.L. Bauer, H. Braselmann, M. Henke, D. Mattem, A. Walch, K. Unger, M. Baudis, S. Lassmann, R. Huber, J. Wienberg, M. Werner and H.F. Zitzelsberger, Chromosomal changes char-acterize head and neck cancer with poor prognosis, J. Mol. Med 86 (2008), 1353-1365.
2. A. Bergamaschi, Y.H. Kim, P. Wang, T. Sortie, T. Hernandez-Boussard, P.E. Lonning, R. Tibshirani, A.L. Borresen-Dale and J.R. Pollack, Distinct patterns of DNA copy number alter-ation are associated with different clinicopathological features and gene-expression subtypes of breast cancer, Genes Chromo-somes Cancer 45 (2006), 1033-1040.
3. U. Bockmuhl, K. Schluns, I. Kuchler, S. Petersen and I. Pe-tersen, Genetic imbalances with impact on survival in head and neck cancer patients, Am. J. Pathol. 157 (2000), 369-375.
4. J. Bolt, Q.N. Vo, W.J. Kim, A.J. McWhorter, J. Thomson, M.E. Hagensee, P. Friedlander, K.D. Brown, and J. Gilbert, The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms, Oral Oncol. 41 (2005), 1013-1020.
5. B.J.M. Braakhuis, P.J.F Snijders, W.J.H. Keune, C.J.L.M. Mei-jer, H.J. Ruijter-Schippers, C.R. Leemans and R.H. Brakenhoff, Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus, J. Natl. Cancer Inst. 96 (2004), 998-1006.
6. J.A. Brennan, J.O. Boyle, W.M. Koch, S.N. Goodman, R.H. Hruban, Y.J. Eby, M.J. Couch, A.A. Forastiere and D. Sidran-sky, Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck, N. Engl. J. Med. 332 (1995), 712-717.
7. S.F. Chin, A.E. Teschendorff, J.C. Marioni, Y. Wang, N.L. Barbosa-Morais, N.P. Thorne, J.L. Costa, S.E. Pinder, M.A. van de Wiel, A.R. Green, I.O. Ellis, P.L. Porter, S. Tavare, J.D. Brenton, B. Ylstra and C Caldas, High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer, Genome Biol. 8 (2007), R215.
8. S.F. Chin, Y. Wang, N.P. Thorne, A.E. Teschendorff, S.E. Pin-der, M. Vias, A. Naderi, I. Roberts, N.L. Barbosa-Morais, M.J. Garcia, N.G. Iyer, T. Kranjac, J.F. Robertson, S. Aparicio, S. Tavare, I. Ellis, J.D. Brenton and C. Caldas, Using array-comparative genomic hybridization to define molecular por-traits of primary breast cancers, Oncogene 26 (2007), 1959-1970.
9. J. Decker and J.C. Goldstein, Risk factors in head and neck cancer, N. Engl. J. Med. 306 (1982), 1151-1155.
10. S. Derks, C. Postma, B. Carvalho, S.M. van den Bosch, P.T. Moerkerk, J.G. Herman, M.P. Weijenberg, A.P. de Bruine, G.A. Meijer and M. van Engeland, Integrated analysis of chromoso-mal, microsatellite and epigenetic instability in colorectal can-cer identifies specific associations between promoter methyla-tion of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations, Carcinogenesis 29 (2008), 434-439.
11. C. Fakhry, W.H. Westra, S. Li, A. Cmelak, J.A. Ridge, H. Pinto, A. Forastiere and M.L. Gillison, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical, trial, J. Natl. Cancer Inst. 100 (2008), 261-269.
12. C. Garnis, C. Baldwin, L. Zhang, M.P. Rosin and W.L. Lam, Use of complete coverage array comparative genomic hy-bridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas, Cancer Res. 63 (2003), 8582-8585.
13. M.L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, and R. Viscidi, Distinct risk factor profiles for human papillomavirus type 16-positive and human papillo-mavirus type 16-negative head and neck cancers, J. Natl. Can-cer Inst. 100 (2008), 407-420.
14. M.A. Ginos, G.P. Page, B.S. Michalowicz, K.J. Patel, S.E. Volker, S.E. Pambuccian, F.G. Ondrey, G.L. Adams and P.M. Gaffney, Identification of a gene expression signature associ-ated with recurrent disease in squamous cell carcinoma of the head and neck, Cancer Res. 64 (2004), 55-63.
15. G. Goessel, M. Quante, W.C. Hahn, H. Harada, S. Heeg, Y. Suliman, M. Doebele, A. von Werder, C. Fulda, H. Naka-gawa, A.K. Rustgi, H.E. Blum, and O.G. Opitz, Creating oral squamous cancer cells: a cellular model of oral-esophageal car-cinogenesis, Proc. Natl. Acad. Sci. USA 102 (2005), 15599-15604.
16. S.M. Gollin, Chromosomal alterations in squamous cell carci-nomas of the head and neck: Window to the biology of disease, Head Neck 23 (2001), 238-253.
17. S.L. Harris and A.J. Levine, The p53 pathway: positive and negative feedback loops, Oncogene 24 (2005), 2899-2908.
18. D.C. Hassane, M.L. Guzman, C. Corbett, X. Li, R. Abboud, R Young, J.L. Liesveld, M. Carroll and C.T. Jordan, Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression, data, Blood 111 (2008), 5654-5662.
19. T. Ishizuka, C. Tanabe, H. Sakamoto, K. Aoyagi, M. Maekawa, N. Matsukura, A. Tokunaga, T. Tajiri, T. Yoshida, M. Ter-ada and H. Sasaki, Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH, Biochem. Bio-phys. Res. Commun. 296 (2002), 152-155.
20. C. Jin, Y. Jin, J. Wennerberg, K. Annertz, J. Enoksson and R Mertens, Cytogenetic abnormalities in 106 oral squamous cell carcinomas, Cancer Genet. Cytogen. 164 (2006), 44-53.
21. W.M. Koch, M. Lango, D. Sewell, M. Zahurak and D. Sidran-sky, Head and neck cancer in nonsmokers: a distinct clinical and molecular entity, Laryngoscope 109 (1999), 1544-1551.
22. R Lewin, S.E. Norell, H. Johansson, P. Gustavsson, J. Wenner-berg, A. Biorklund and L.E. Rutqvist, Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden, Cancer 82 (1998), 1367-1675.
23. A.M. Mandard, P. Hainaut and M. Hollstein, Genetic steps in the development of squamous cell carcinoma of the esophagus, Mutat. Res. 462 (2000), 335-342.
24. C.L. Martin, S.C. Reshmi, T. Ried, W. Gottberg, J.W. Wilson, J.K. Reddy, P. Khanna, J.T. Johnson, E.N. Myers and S.M. Gollin, Chromosomal imbalances in oral squamous cell carci-noma: examination of 31 cell lines and review of the literature, Oral Oncol. 44 (2008), 369-382.
25. A.B. Olshen, E.S. Venkatraman, R. Lucito and M. Wigler, Cir-cular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics 5 (2004), 557-572.
26. H.S. Patmore, J.N. Ashman, N.D. Stafford, H.K. Berrieman, A. MacDonald, J. Greenman and L. Cawkwell, Genetic analy-sis of head and neck squamous cell carcinoma using compara-tive genomic hybridisation identifies specific aberrations asso-ciated with laryngeal, origin, Cancer Lett. 258 (2007), 55-62.
27. M.L. Poeta, J. Manola, M.A. Goldwasser, A. Forastiere, N. Benoit, J.A. Califano, J.A. Ridge, J. Goodwin, D. Kenady, J. Saunders, W. Westra, D. Sidransky and W.M. Koch, TP53 mutations and survival in squamous-cell carcinoma of the head and neck, N. Engl. J. Med. 357 (2007), 2552-2561.
28. H.K. Seitz and R Stickel, Molecular mechanisms of alcohol-mediated carcinogenesis, Nat. Rev. Cancer 7 (2007), 599-612.
29. B. Singh, V.B. Wreesmann, D. Pfister, A. Poluri, A.R. Shaha, D. Kraus, J.P. Shah and RH. Rao, Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure, BMC Genet. 3 (2002), 22-29.
30. R.J. Slebos, Y. Yi, K. Ely, J. Carter, A. Evjen, X. Zhang, Y. Shyr, B.M. Murphy, A.J. Cmelak, B.B. Burkey, J.L. Netter-ville, S. Levy, W.G. Yarbrough and C.H. Chung, Gene expres-sion differences associated with human papillomavirus status in head and neck squamous cell carcinoma, Clin. Cancer Res. 12 (2006), 701-709.
31. S.J. Smeets, B. J.M. Braakhuis, S. Abbas, P.J.F. Snijders, B. Yl-stra, M.A. van de Wiel, G.A. Meijer, C.R. Leemans and R.H. Brakenhoff, Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or with-out oncogene-expressing human papillomavirus, Oncogene 25 (2006), 2558-2564.
32. A.M. Snijders, B.L. Schmidt, J. Fridlyand, N. Dekker, D. Pinkel, R.C. Jordan and D.G. Albertson, Rare amplicons im-plicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma, Oncogene 24 (2005), 4232-4242.
33. L.H. Sobin and C. Wittekind, TNM Classification of Malignant Tumours, 6th edn, Wiley-Liss, New York, 2002.
34. A. Sparano, K.M. Quesnelle, M.S. Kumar, Y. Wang, A.J. Sylvester, M. Feldman, D.A. Sewell, G.S. Weinstein and M.S. Brose, Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization, Laryngo-scope 116 (2006), 735-741.
35. A. Umar, C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. Ruschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, R Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.R Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman and S. Srivastava, Revised Bethesda Guidelines for hereditary non-polyposis colorectal cancer (Lynch syndrome) and microsatel-lite instability, J. Natl. Cancer Inst. 96 (2004), 261-268.
36. M.A. van de Wiel, K.I. Kim, S.J. Vosse, W.N. van Wieringen, S.M. Wilting and B. Ylstra, CGHcall: calling aberrations for array CGH tumor profiles, Bioinformatics 23 (2007), 892-894.
37. M.A. van de Wiel and W.N. van Wieringen, CGHregions: di-mension reduction for array CGH data with minimal informa-tion loss, Cancer Informatics 2 (2007), 55-63.
38. V.M. van Houten, P.J.F. Snijders, M.W. van den Brekel, J.A. Kummer, C.J.L.M. Meijer, B. van Leeuwen, F. Denkers, L.E. Smeele, G.B. Snow and R.H. Brakenhoff, Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas, Int. J. Cancer 93 (2001), 232-235.
39. V.M. van Houten, M.P. Tabor, M.W. van den Brekel, J.A. Kum-mer, R Denkers, J. Dijkstra, R. Leemans, I. van der Waal, G.B. Snow and R.H. Brakenhoff, Mutated p53 as a molecular marker for the diagnosis of head and neck cancer, J. Pathol. 198 (2002), 476-486.
40. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Wit-teveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Lins-ley, R. Bernards and S.H. Friend, Gene expression profiling predicts clinical outcome of breast cancer, Nature 415 (2002), 530-536.
41. W.N. Van Wieringen, M.A. Van De Wiel and B. Ylstra, Weighted clustering of called array CGH data, Biostatistics 9 (2008), 484-500.
42. T. Wiest, E. Schwarz, C. Enders, C. Flechtenmacher and F.X. Bosch, Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control, Oncogene 21 (2002), 1510-1517.
43. F.P. Worden, B. Kumar, J.S. Lee, G.T. Wolf, K.G. Cordell, J.M. Taylor, S.G. Urba, A. Eisbruch, T.N. Teknos, D.B. Chep-eha, M.E. Prince, C.I. Tsien, N.J. D'Silva, K. Yang, D.M. Kur-nit, H.L. Mason, T.H. Miller, N.E. Wallace, C.R. Bradford and T.E. Carey, Chemoselection as a strategy for organ preserva-tion in advanced oropharynx cancer: response and survival pos-itively associated with HPV 16 copy number, J. Clin, Oncol. 26 (2008), 3138-3146.
44. V.B. Wreesmann, W. Shi, H.T. Thaler, A. Poluri, D.H. Kraus, D. Pfister, A.R. Shaha, J.P. Shah, P.H. Rao and B. Singh, Iden-tification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck, J. Clin. Oncol. 22 (2004), 3965-3972.
45. V.B. Wreesmann and B. Singh, Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: bi-ologic insights and clinical opportunities, J. Oral Pathol. Med. 34 (2005), 449-459.